Professional Documents
Culture Documents
TOPIC 3 7 P
TOPIC 3 7 P
1
9/6/2022
DISORDERS OF ERYTHROPOIETIN
2
9/6/2022
BLOOD COMPONENTS
Water: 93-95% Water:
Plasma: 50-60% 93~95% (plasma); 65~68% (RBC); 81~86% (whole blood).
Solutes: 5-7% Proteins: Solvent, humoral balance, osmotic pressure.
Nutrients Electrolytes:
Whole Products Na+, K+, Mg2+, Cl-, HCO3-, etc. Cell shape, pH.
37-48% (female)
Blood pH:
Hemoglobin (Hb):
Normal interval: 7.35~7.45.
120-160g/L (male), 110-150g/L (female)
Regulated by lung and kidney.
Function: carry gases.
Viscosity:
Others:
Friction of molecules and cells in blood.
carbohydrates, lipids, amino acid, pigments,
hormones, gas (O2, CO2), and others like urea, uric Relative viscosity:
acid. Whole blood: 4~5 times to water (RBC).
Plasma: 1.6~2.4 times to water (Proteins).
Anemia or body fluid loss.
3
9/6/2022
Crystal osmotic pressure: 298.7 mmol/L. RBC 120 days 2.5 109/L
Maintain shape and size of cells.
Neutrophil 7 hours 0.85 109/L
Colloid osmotic pressure: 1.3 mmol/L.
Retain blood volume Platelet 10 days 2. 5 109/L
Physical properties
Permeability:
Deformation:
4
9/6/2022
Lack of folic acid and vitb12: give rise to immature cells due to
DNA synthesis derangement.
•REGULATION OF ERYTHROPOIESIS:
Megaloblast anemia.
HYPOXIA: EPO RBC
Hemopoitic stem cell (uncommitted progenitor)
Erythrocytic progenitor (committed progenitor)
EPO
Pronormblast (precursor)
Normoblast, Reticulocyte
Mature RBC (without nucleus)
5
9/6/2022
Monocytes:
15~30m, 0.12 ~ 0.8109/L, 3 ~ 8%.
Neutrophil: Monocytes-macrophages system:
10~12m, 2.0~7.0109/L, 60-70%. Monocytes (in blood) wander into tissues and become
macrophages (50 ~ 80 m). Stronger phagocytosis.
Function:
Contain many kinds of cytokines such as CSF, ILs, TNF, INF-
Phagocytosis: older cells, becteria, dead tissues, and a,b.
other foreign substances.
Roles:
To execute non-specific immune activity in first front.
Engulf and clear: bacteria, vermins, older, necrotic tissues,
dead neutrophils, dead cells and fragments.
Activate lymphocytes to execute specific immune
COMPOSITION AND FUNCTIONS response.
Recognize and kill cancer cells.
Produce CSF, Ils, TNF, INF-, , regulate growth of
granulocytes.
Lymphocytes: Eosinophils
0.8~4.0109/L, 20 ~ 40%. 0.02~0.5 109/L, 0.5~5%.
Development of lymphocyte: Functions:
T lymphocyte: Inhibit allergic reaction induced by basophils:
lymphocytic stem cells T lymphocytes (thymus gland).
Produce PGE to inhibit secretion of basophils;
B lymphocyte:
Engulf substances secreted by basophils;
lymphocytic stem cells B lymphocytes (lymphoid tissue).
PLATELET
Hemostasis:
Basophils The process of blood clotting and then the subsequent
dissolution of the clot.
0.0~1.0 109/L, 0~1%.
Largecytoplastmic granules contain heparin, 5-
hydroxytryptamine and histamine. Platelet activation adhension aggregation clot thrombus FDP
6
9/6/2022
Aggregation:
Physical properties
Activated platelets aggregate together.
Adhesion: Activation of platelets: induced by thrombin.
Mediated by von Willebrand factor (vWF). Thrombin + receptor initiate signal cascade.
vWF is producted and stored in a-granules of platelets. Also G-protein, and phospholipase C(PLC-g).
synthesized by megakaryocytes. PLC-g IP3 and DAG formation.
Function of vWF: IP3 Ca2+ , and DAG PKC.
Toact as a bridge between glycoprotein on the surface of
platelets (GPIb/IX) and collagen fibrils.
Serves as a carrier protein for factor VIII.
Mechanisms:
Ca2+ phospholipase A2 (PLA2) arachidonic acid thromboxane
von Willebrand Disease (vWD): deficiency in vWF a patient A2 (TXA2)
with long bleeding time, a low level of factor vWF/VIII
complex. PKC ADP fibrinogen to adhere to two platelet surface
glycoproteins (GPIIb and GPIIIa) fibrinogen-induced platelet
Bernard-Soulier Syndrome:deficiency of glycoprotein Ib/IX. aggregation.
Glanzmann-Thrombasthenia, deficiency of glycoprotein IIb/IIIa.
Contractile function:
PLC-g Ca2+ myosin light chain kinase (MLCK)
MLCK phosphorylation of light chain of myosin
Myosin interacts with actin
Platelet morphology, motility, and clot retraction.